Introducing HFX

HFX is the sum of excellence in four key areas to support you in providing your patients the best care.

HFX

Now Available for Non-Surgical
Back Pain Patients

Recently approved by the FDA with a specific indication for Non-Surgical Back Pain (NSBP) patients.

LEARN ABOUT NSBP OUTCOMES

Long-Term Responder Rates
Now Also Available for Painful Diabetic Neuropathy

Now Also Available for
Painful Diabetic Neuropathy

The SCS system approved by the FDA with a specific indication for painful diabetic neuropathy.

LEARN MORE ABOUT HFX FOR PDN

More Innovative Technologies

More Innovative Technologies

A versatile neuromodulation platform designed for enduring patient success.

Learn About Omnia Powered By Hfx Connect

Ongoing Patient Services & Support

End-to-end partnership with you, supporting patient care and optimal outcomes.

Learn About Services & Support

Maximum Versatility With
Advanced Therapies

Offering maximum versatility with multiple mechanisms to meet the diverse needs of your patients.

Learn About Advanced Therapies

Meaningful Evidence To Support Your Practice

Nevro pursues clinical research to better support healthcare providers in treating chronic pain. No other spinal cord stimulation (SCS) technology has this wealth of quality clinical data to back its technology.

View Meaningful Evidence
Neurosurgery Neuromodulation Annals
Anesthesiology Pain Medicine

More of What They Love

At Nevro, our success is measured by our patients satisfaction. 88% percent of patients treated with 10 kHz Therapy are more independent because of their reduced pain.1